InFLAMES: Predicting Onset of Type 1 Diabetes with Novel Blood Biomarkers
InFLAMES (Innovation Ecosystem based on the Immune System) is a Finnish research flagship that aims at identifying novel drug targets using the most modern technological platforms and finding novel diagnostic tools to identify the patients benefitting from personalised therapies.